DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1023997
Title:
A Multiplex Cancer/Testis Antigen-Based Biomarker Panel to Predict the Aggressive Phenotype of Prostate Cancer
Corporate Author:
Johns Hopkins University Baltimore United States
Report Date:
2016-09-01
Abstract:
The CancerTestis Antigens CTAs are a group of proteins normally confined to germ cells but aberrantly expressed in several cancers. The central hypothesis of this grant application is that a CTA-based biomarker can be used to discern LPCa from MPCa. In the first year of this grant, we determined gene expression of 22 candidate CTAs by Nanostring and validated by qRT-PCR. During the second year of the grant, we used ROC curve analysis and identified 8 CTA genes CEP55, NUF2,PAGE4, PBK, RQCD1, SPAG4, SSX2 and TTK, which expression pattern is significant different between aggressive and indolent tumors.
Descriptive Note:
Technical Report,30 Sep 2012,29 Jun 2016
Pages:
0032
Distribution Statement:
Approved For Public Release;
File Size:
2.04MB
